Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Phase I/II trial of ISIS3521, an antisense inhibitor of PKC alpha, with carboplatin and paclitaxel in non-small cell lung cancer. Yuen, A., Halsey, J., Lum, B., Fisher, G., Advani, R., Geary, R., Kwoh, T. J., Holmlund, J. T., Dorr, A., Sikic, B. I. AMER ASSOC CANCER RESEARCH. 2000: 4572S
View details for Web of Science ID 000165409000487